Login / Signup

Teriparatide administration by the Omnipod pump: preliminary experience from two cases with refractory hypoparathyroidism.

Karine AouchicheRachel ReynaudVincent AmodruThierry BrueThomas Cuny
Published in: Endocrine (2022)
Continuous administration of teriparatide through Omnipod® appears as an efficient therapeutic option in refractory hypoPTH, whose administration to the patient can be assisted by medically-supervised protocol.
Keyphrases
  • bone mineral density
  • randomized controlled trial
  • machine learning
  • postmenopausal women
  • body composition